iBio, Inc: director William D Clark received 38,000 shares

What happened William D Clark, a director of iBio, Inc., received a grant of 38,000 derivative shares (options) at $0.00 on Oct 14, 2026, as reported on a Form 4 filed Oct 15, 2026.

Key details

• Transaction date and price: Oct 14, 2026; 38,000 shares at $0.00 (transaction code A: award/grant; derivative).
• Shares owned after the transaction: the filing does not report shares owned after the transaction.
• Vesting footnote: the options vest pro rata in monthly installments over 12 months, with the first installment vesting one month after the grant date, subject to continued service through each vesting date.
• Form 4 filing date: Oct 15, 2026.

Why it may matter

• This was an option grant (a derivative award), not a market purchase or sale.
• The filing does not show why the insider traded or why the company acted.